awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35999062-A787D640-1911-4A21-90A5-58C30F114409
Q35999062-A787D640-1911-4A21-90A5-58C30F114409
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35999062-A787D640-1911-4A21-90A5-58C30F114409
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla
P2860
Q35999062-A787D640-1911-4A21-90A5-58C30F114409
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35999062-A787D640-1911-4A21-90A5-58C30F114409
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
264473f1d6b41a85ab8fd020bd8d2e802d86a2a0
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.